nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—malaria	0.502	1	CbGaD
Naloxone—SLCO1A2—Quinine—malaria	0.0475	0.142	CbGbCtD
Naloxone—SLCO1A2—Quinidine—malaria	0.0418	0.125	CbGbCtD
Naloxone—CYP2C8—Sulfadiazine—malaria	0.0368	0.11	CbGbCtD
Naloxone—CYP2C8—Pyrimethamine—malaria	0.0368	0.11	CbGbCtD
Naloxone—CYP3A4—Clindamycin—malaria	0.026	0.0778	CbGbCtD
Naloxone—CYP2C8—Quinine—malaria	0.019	0.0568	CbGbCtD
Naloxone—CYP2C8—Quinidine—malaria	0.0167	0.0499	CbGbCtD
Naloxone—CYP3A4—Sulfadiazine—malaria	0.0149	0.0447	CbGbCtD
Naloxone—CYP2C8—Dapsone—malaria	0.0144	0.043	CbGbCtD
Naloxone—ABCB1—Quinine—malaria	0.0128	0.0384	CbGbCtD
Naloxone—CYP3A4—Artemether—malaria	0.0127	0.038	CbGbCtD
Naloxone—CYP3A4—Proguanil—malaria	0.0119	0.0357	CbGbCtD
Naloxone—CYP3A4—Doxycycline—malaria	0.0113	0.0339	CbGbCtD
Naloxone—ABCB1—Quinidine—malaria	0.0113	0.0338	CbGbCtD
Naloxone—CYP3A4—Quinine—malaria	0.00769	0.023	CbGbCtD
Naloxone—CYP3A4—Quinidine—malaria	0.00676	0.0202	CbGbCtD
Naloxone—CYP3A4—Dapsone—malaria	0.00583	0.0174	CbGbCtD
Naloxone—CREB1—blood plasma—malaria	0.00317	0.0799	CbGeAlD
Naloxone—TLR4—blood—malaria	0.00264	0.0665	CbGeAlD
Naloxone—TLR4—bone marrow—malaria	0.00255	0.0643	CbGeAlD
Naloxone—TLR4—liver—malaria	0.00206	0.052	CbGeAlD
Naloxone—Excitement—Quinidine—malaria	0.00187	0.0276	CcSEcCtD
Naloxone—Excitement—Quinine—malaria	0.00187	0.0276	CcSEcCtD
Naloxone—CREB1—saliva-secreting gland—malaria	0.00184	0.0463	CbGeAlD
Naloxone—CREB1—hematopoietic system—malaria	0.00175	0.0442	CbGeAlD
Naloxone—Excitement—Quinidine barbiturate—malaria	0.00169	0.0249	CcSEcCtD
Naloxone—TLR4—brain—malaria	0.00164	0.0412	CbGeAlD
Naloxone—CREB1—kidney—malaria	0.00144	0.0362	CbGeAlD
Naloxone—Abdominal cramps—Clindamycin—malaria	0.00139	0.0205	CcSEcCtD
Naloxone—CREB1—digestive system—malaria	0.00122	0.0307	CbGeAlD
Naloxone—Ventricular fibrillation—Quinidine—malaria	0.0012	0.0177	CcSEcCtD
Naloxone—Ventricular fibrillation—Quinine—malaria	0.0012	0.0177	CcSEcCtD
Naloxone—CREB1—blood—malaria	0.00116	0.0293	CbGeAlD
Naloxone—OPRD1—kidney—malaria	0.00113	0.0286	CbGeAlD
Naloxone—CREB1—bone marrow—malaria	0.00112	0.0283	CbGeAlD
Naloxone—Ventricular fibrillation—Quinidine barbiturate—malaria	0.00108	0.016	CcSEcCtD
Naloxone—CYP2C8—blood plasma—malaria	0.00103	0.0259	CbGeAlD
Naloxone—Hallucination—Proguanil—malaria	0.000947	0.014	CcSEcCtD
Naloxone—OPRM1—hematopoietic system—malaria	0.000944	0.0238	CbGeAlD
Naloxone—Ventricular tachycardia—Quinidine—malaria	0.000919	0.0136	CcSEcCtD
Naloxone—Ventricular tachycardia—Quinine—malaria	0.000919	0.0136	CcSEcCtD
Naloxone—CREB1—liver—malaria	0.000907	0.0229	CbGeAlD
Naloxone—Mediastinal disorder—Proguanil—malaria	0.000858	0.0127	CcSEcCtD
Naloxone—Coma—Quinidine—malaria	0.00084	0.0124	CcSEcCtD
Naloxone—Coma—Quinine—malaria	0.00084	0.0124	CcSEcCtD
Naloxone—Mental disorder—Proguanil—malaria	0.000834	0.0123	CcSEcCtD
Naloxone—Ventricular tachycardia—Quinidine barbiturate—malaria	0.00083	0.0122	CcSEcCtD
Naloxone—Injection site reaction—Quinidine barbiturate—malaria	0.000825	0.0122	CcSEcCtD
Naloxone—Pulmonary oedema—Quinine—malaria	0.000818	0.0121	CcSEcCtD
Naloxone—Pulmonary oedema—Quinidine—malaria	0.000818	0.0121	CcSEcCtD
Naloxone—SLCO1A2—hematopoietic system—malaria	0.000813	0.0205	CbGeAlD
Naloxone—Coma—Quinidine barbiturate—malaria	0.000758	0.0112	CcSEcCtD
Naloxone—Pulmonary oedema—Quinidine barbiturate—malaria	0.000738	0.0109	CcSEcCtD
Naloxone—Hyperkinesia—Quinidine barbiturate—malaria	0.000724	0.0107	CcSEcCtD
Naloxone—CREB1—brain—malaria	0.00072	0.0182	CbGeAlD
Naloxone—Depression—Sulfadiazine—malaria	0.000702	0.0103	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000701	0.0103	CcSEcCtD
Naloxone—CYP3A4—blood plasma—malaria	0.000696	0.0175	CbGeAlD
Naloxone—ESR1—hematopoietic system—malaria	0.000689	0.0174	CbGeAlD
Naloxone—SLCO1A2—kidney—malaria	0.000666	0.0168	CbGeAlD
Naloxone—Nervous system disorder—Proguanil—malaria	0.000663	0.00978	CcSEcCtD
Naloxone—Skin disorder—Proguanil—malaria	0.000657	0.00969	CcSEcCtD
Naloxone—Cardiac arrest—Clindamycin—malaria	0.000647	0.00954	CcSEcCtD
Naloxone—Cardiac arrest—Quinine—malaria	0.000635	0.00936	CcSEcCtD
Naloxone—Cardiac arrest—Quinidine—malaria	0.000635	0.00936	CcSEcCtD
Naloxone—Nasopharyngitis—Dapsone—malaria	0.000629	0.00927	CcSEcCtD
Naloxone—Hallucination—Sulfadiazine—malaria	0.000629	0.00927	CcSEcCtD
Naloxone—OPRM1—blood—malaria	0.000626	0.0158	CbGeAlD
Naloxone—Gastrointestinal disorder—Proguanil—malaria	0.000584	0.00861	CcSEcCtD
Naloxone—Irritability—Quinidine barbiturate—malaria	0.000575	0.00848	CcSEcCtD
Naloxone—Cardiac arrest—Quinidine barbiturate—malaria	0.000573	0.00844	CcSEcCtD
Naloxone—OPRD1—brain—malaria	0.000569	0.0144	CbGeAlD
Naloxone—CYP2C8—hematopoietic system—malaria	0.000568	0.0143	CbGeAlD
Naloxone—Chills—Sulfadiazine—malaria	0.000567	0.00836	CcSEcCtD
Naloxone—SLCO1A2—digestive system—malaria	0.000565	0.0143	CbGeAlD
Naloxone—ESR1—kidney—malaria	0.000565	0.0142	CbGeAlD
Naloxone—Vomiting—Pyrimethamine—malaria	0.000552	0.00814	CcSEcCtD
Naloxone—OPRK1—brain—malaria	0.000546	0.0138	CbGeAlD
Naloxone—Abdominal pain—Proguanil—malaria	0.000535	0.00788	CcSEcCtD
Naloxone—Body temperature increased—Proguanil—malaria	0.000535	0.00788	CcSEcCtD
Naloxone—Sweating—Quinidine—malaria	0.000493	0.00727	CcSEcCtD
Naloxone—Sweating—Quinine—malaria	0.000493	0.00727	CcSEcCtD
Naloxone—ABCB1—blood plasma—malaria	0.000492	0.0124	CbGeAlD
Naloxone—ESR1—digestive system—malaria	0.000479	0.0121	CbGeAlD
Naloxone—Convulsion—Sulfadiazine—malaria	0.000477	0.00703	CcSEcCtD
Naloxone—CYP2C8—kidney—malaria	0.000465	0.0117	CbGeAlD
Naloxone—Diarrhoea—Proguanil—malaria	0.000463	0.00682	CcSEcCtD
Naloxone—ESR1—blood—malaria	0.000457	0.0115	CbGeAlD
Naloxone—Sweating—Quinidine barbiturate—malaria	0.000445	0.00656	CcSEcCtD
Naloxone—Sweating—Pentoxifylline—malaria	0.000444	0.00655	CcSEcCtD
Naloxone—Flushing—Clindamycin—malaria	0.000437	0.00644	CcSEcCtD
Naloxone—Vomiting—Proguanil—malaria	0.00043	0.00634	CcSEcCtD
Naloxone—Cardiac disorder—Quinine—malaria	0.000428	0.00632	CcSEcCtD
Naloxone—Cardiac disorder—Quinidine—malaria	0.000428	0.00632	CcSEcCtD
Naloxone—Flushing—Quinine—malaria	0.000428	0.00632	CcSEcCtD
Naloxone—Flushing—Quinidine—malaria	0.000428	0.00632	CcSEcCtD
Naloxone—SLCO1A2—liver—malaria	0.000421	0.0106	CbGeAlD
Naloxone—ALB—liver—malaria	0.000419	0.0106	CbGeAlD
Naloxone—Mediastinal disorder—Quinidine—malaria	0.000416	0.00613	CcSEcCtD
Naloxone—Mediastinal disorder—Quinine—malaria	0.000416	0.00613	CcSEcCtD
Naloxone—Hallucination—Quinidine barbiturate—malaria	0.000415	0.00611	CcSEcCtD
Naloxone—Chills—Quinidine—malaria	0.000414	0.00611	CcSEcCtD
Naloxone—Chills—Quinine—malaria	0.000414	0.00611	CcSEcCtD
Naloxone—Mental disorder—Quinine—malaria	0.000404	0.00596	CcSEcCtD
Naloxone—Mental disorder—Quinidine—malaria	0.000404	0.00596	CcSEcCtD
Naloxone—Nausea—Proguanil—malaria	0.000402	0.00592	CcSEcCtD
Naloxone—OPRM1—brain—malaria	0.000388	0.00979	CbGeAlD
Naloxone—Gastrointestinal disorder—Sulfadiazine—malaria	0.000388	0.00571	CcSEcCtD
Naloxone—Cardiac disorder—Quinidine barbiturate—malaria	0.000387	0.0057	CcSEcCtD
Naloxone—Flushing—Quinidine barbiturate—malaria	0.000387	0.0057	CcSEcCtD
Naloxone—Flushing—Pentoxifylline—malaria	0.000386	0.00569	CcSEcCtD
Naloxone—CYP3A4—hematopoietic system—malaria	0.000385	0.0097	CbGeAlD
Naloxone—Tremor—Quinidine—malaria	0.000377	0.00555	CcSEcCtD
Naloxone—Tremor—Quinine—malaria	0.000377	0.00555	CcSEcCtD
Naloxone—CYP2C8—blood—malaria	0.000376	0.00949	CbGeAlD
Naloxone—Mediastinal disorder—Quinidine barbiturate—malaria	0.000375	0.00554	CcSEcCtD
Naloxone—Chills—Quinidine barbiturate—malaria	0.000374	0.00551	CcSEcCtD
Naloxone—Agitation—Quinidine—malaria	0.000369	0.00545	CcSEcCtD
Naloxone—Agitation—Quinine—malaria	0.000369	0.00545	CcSEcCtD
Naloxone—Mental disorder—Quinidine barbiturate—malaria	0.000365	0.00538	CcSEcCtD
Naloxone—ESR1—liver—malaria	0.000357	0.00901	CbGeAlD
Naloxone—Tension—Quinidine barbiturate—malaria	0.000356	0.00525	CcSEcCtD
Naloxone—Tension—Pentoxifylline—malaria	0.000355	0.00524	CcSEcCtD
Naloxone—Abdominal pain—Sulfadiazine—malaria	0.000355	0.00523	CcSEcCtD
Naloxone—Body temperature increased—Sulfadiazine—malaria	0.000355	0.00523	CcSEcCtD
Naloxone—Hypertension—Clindamycin—malaria	0.000354	0.00521	CcSEcCtD
Naloxone—Nervousness—Quinidine barbiturate—malaria	0.000352	0.00519	CcSEcCtD
Naloxone—Nervousness—Pentoxifylline—malaria	0.000352	0.00518	CcSEcCtD
Naloxone—Convulsion—Quinidine—malaria	0.000348	0.00513	CcSEcCtD
Naloxone—Convulsion—Quinine—malaria	0.000348	0.00513	CcSEcCtD
Naloxone—Tremor—Quinidine barbiturate—malaria	0.00034	0.00501	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00034	0.00501	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00034	0.00501	CcSEcCtD
Naloxone—Tremor—Pentoxifylline—malaria	0.000339	0.005	CcSEcCtD
Naloxone—Tachycardia—Dapsone—malaria	0.000337	0.00497	CcSEcCtD
Naloxone—SLCO1A2—brain—malaria	0.000334	0.00843	CbGeAlD
Naloxone—Agitation—Quinidine barbiturate—malaria	0.000333	0.00491	CcSEcCtD
Naloxone—Agitation—Pentoxifylline—malaria	0.000333	0.00491	CcSEcCtD
Naloxone—ALB—brain—malaria	0.000332	0.00838	CbGeAlD
Naloxone—Nervous system disorder—Quinidine—malaria	0.000322	0.00474	CcSEcCtD
Naloxone—Nervous system disorder—Quinine—malaria	0.000322	0.00474	CcSEcCtD
Naloxone—Tachycardia—Quinidine—malaria	0.00032	0.00472	CcSEcCtD
Naloxone—Tachycardia—Quinine—malaria	0.00032	0.00472	CcSEcCtD
Naloxone—Skin disorder—Quinine—malaria	0.000319	0.0047	CcSEcCtD
Naloxone—Skin disorder—Quinidine—malaria	0.000319	0.0047	CcSEcCtD
Naloxone—Hyperhidrosis—Quinidine—malaria	0.000317	0.00467	CcSEcCtD
Naloxone—Hyperhidrosis—Quinine—malaria	0.000317	0.00467	CcSEcCtD
Naloxone—CYP3A4—kidney—malaria	0.000315	0.00795	CbGeAlD
Naloxone—Convulsion—Quinidine barbiturate—malaria	0.000314	0.00463	CcSEcCtD
Naloxone—Convulsion—Pentoxifylline—malaria	0.000314	0.00462	CcSEcCtD
Naloxone—Hypertension—Pentoxifylline—malaria	0.000313	0.00461	CcSEcCtD
Naloxone—Diarrhoea—Sulfadiazine—malaria	0.000307	0.00453	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000307	0.00452	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000306	0.00451	CcSEcCtD
Naloxone—Dyspnoea—Clindamycin—malaria	0.000298	0.00439	CcSEcCtD
Naloxone—CYP2C8—liver—malaria	0.000294	0.00742	CbGeAlD
Naloxone—Dyspnoea—Quinidine—malaria	0.000292	0.00431	CcSEcCtD
Naloxone—Dyspnoea—Quinine—malaria	0.000292	0.00431	CcSEcCtD
Naloxone—Nervous system disorder—Quinidine barbiturate—malaria	0.00029	0.00428	CcSEcCtD
Naloxone—Tachycardia—Quinidine barbiturate—malaria	0.000289	0.00426	CcSEcCtD
Naloxone—Gastrointestinal disorder—Clindamycin—malaria	0.000289	0.00426	CcSEcCtD
Naloxone—Tachycardia—Pentoxifylline—malaria	0.000288	0.00425	CcSEcCtD
Naloxone—Skin disorder—Quinidine barbiturate—malaria	0.000288	0.00424	CcSEcCtD
Naloxone—Skin disorder—Pentoxifylline—malaria	0.000287	0.00423	CcSEcCtD
Naloxone—Hyperhidrosis—Quinidine barbiturate—malaria	0.000286	0.00422	CcSEcCtD
Naloxone—Pain—Clindamycin—malaria	0.000286	0.00422	CcSEcCtD
Naloxone—Hyperhidrosis—Pentoxifylline—malaria	0.000286	0.00421	CcSEcCtD
Naloxone—Vomiting—Sulfadiazine—malaria	0.000285	0.00421	CcSEcCtD
Naloxone—ESR1—brain—malaria	0.000283	0.00715	CbGeAlD
Naloxone—Gastrointestinal disorder—Quinidine—malaria	0.000283	0.00417	CcSEcCtD
Naloxone—Gastrointestinal disorder—Quinine—malaria	0.000283	0.00417	CcSEcCtD
Naloxone—Body temperature increased—Dapsone—malaria	0.000273	0.00403	CcSEcCtD
Naloxone—Abdominal pain—Dapsone—malaria	0.000273	0.00403	CcSEcCtD
Naloxone—ABCB1—hematopoietic system—malaria	0.000272	0.00687	CbGeAlD
Naloxone—CYP3A4—digestive system—malaria	0.000267	0.00675	CbGeAlD
Naloxone—Nausea—Sulfadiazine—malaria	0.000267	0.00393	CcSEcCtD
Naloxone—Abdominal pain—Clindamycin—malaria	0.000264	0.0039	CcSEcCtD
Naloxone—Body temperature increased—Clindamycin—malaria	0.000264	0.0039	CcSEcCtD
Naloxone—Dyspnoea—Quinidine barbiturate—malaria	0.000264	0.00389	CcSEcCtD
Naloxone—Dyspnoea—Pentoxifylline—malaria	0.000263	0.00388	CcSEcCtD
Naloxone—Body temperature increased—Quinidine—malaria	0.000259	0.00382	CcSEcCtD
Naloxone—Body temperature increased—Quinine—malaria	0.000259	0.00382	CcSEcCtD
Naloxone—Abdominal pain—Quinine—malaria	0.000259	0.00382	CcSEcCtD
Naloxone—Abdominal pain—Quinidine—malaria	0.000259	0.00382	CcSEcCtD
Naloxone—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000256	0.00377	CcSEcCtD
Naloxone—CYP3A4—blood—malaria	0.000255	0.00643	CbGeAlD
Naloxone—Pain—Quinidine barbiturate—malaria	0.000253	0.00373	CcSEcCtD
Naloxone—Asthenia—Clindamycin—malaria	0.00024	0.00354	CcSEcCtD
Naloxone—Asthenia—Quinine—malaria	0.000235	0.00347	CcSEcCtD
Naloxone—Asthenia—Quinidine—malaria	0.000235	0.00347	CcSEcCtD
Naloxone—Abdominal pain—Quinidine barbiturate—malaria	0.000234	0.00345	CcSEcCtD
Naloxone—Body temperature increased—Quinidine barbiturate—malaria	0.000234	0.00345	CcSEcCtD
Naloxone—Body temperature increased—Pentoxifylline—malaria	0.000234	0.00344	CcSEcCtD
Naloxone—Abdominal pain—Pentoxifylline—malaria	0.000234	0.00344	CcSEcCtD
Naloxone—CYP2C8—brain—malaria	0.000233	0.00589	CbGeAlD
Naloxone—Diarrhoea—Clindamycin—malaria	0.000229	0.00337	CcSEcCtD
Naloxone—Diarrhoea—Quinidine—malaria	0.000224	0.00331	CcSEcCtD
Naloxone—Diarrhoea—Quinine—malaria	0.000224	0.00331	CcSEcCtD
Naloxone—ABCB1—kidney—malaria	0.000223	0.00563	CbGeAlD
Naloxone—Vomiting—Dapsone—malaria	0.00022	0.00324	CcSEcCtD
Naloxone—Vomiting—Clindamycin—malaria	0.000213	0.00313	CcSEcCtD
Naloxone—Asthenia—Quinidine barbiturate—malaria	0.000212	0.00313	CcSEcCtD
Naloxone—Asthenia—Pentoxifylline—malaria	0.000212	0.00313	CcSEcCtD
Naloxone—Vomiting—Quinidine—malaria	0.000209	0.00307	CcSEcCtD
Naloxone—Vomiting—Quinine—malaria	0.000209	0.00307	CcSEcCtD
Naloxone—Nausea—Dapsone—malaria	0.000205	0.00303	CcSEcCtD
Naloxone—Diarrhoea—Quinidine barbiturate—malaria	0.000203	0.00299	CcSEcCtD
Naloxone—Diarrhoea—Pentoxifylline—malaria	0.000202	0.00298	CcSEcCtD
Naloxone—CYP3A4—liver—malaria	0.000199	0.00503	CbGeAlD
Naloxone—Nausea—Clindamycin—malaria	0.000199	0.00293	CcSEcCtD
Naloxone—Nausea—Quinidine—malaria	0.000195	0.00287	CcSEcCtD
Naloxone—Nausea—Quinine—malaria	0.000195	0.00287	CcSEcCtD
Naloxone—ABCB1—digestive system—malaria	0.000189	0.00478	CbGeAlD
Naloxone—Vomiting—Quinidine barbiturate—malaria	0.000188	0.00277	CcSEcCtD
Naloxone—Vomiting—Pentoxifylline—malaria	0.000188	0.00277	CcSEcCtD
Naloxone—ABCB1—blood—malaria	0.00018	0.00455	CbGeAlD
Naloxone—Nausea—Quinidine barbiturate—malaria	0.000176	0.00259	CcSEcCtD
Naloxone—Nausea—Pentoxifylline—malaria	0.000175	0.00259	CcSEcCtD
Naloxone—ABCB1—bone marrow—malaria	0.000175	0.0044	CbGeAlD
Naloxone—ABCB1—liver—malaria	0.000141	0.00356	CbGeAlD
Naloxone—ABCB1—brain—malaria	0.000112	0.00282	CbGeAlD
Naloxone—OPRM1—TCR Signaling Pathway—CD4—malaria	7.06e-05	0.00125	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL2—malaria	7.04e-05	0.00125	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—CD36—malaria	6.82e-05	0.00121	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—NOS2—malaria	6.78e-05	0.0012	CbGpPWpGaD
Naloxone—CREB1—Immune System—CISH—malaria	6.74e-05	0.00119	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—IL1B—malaria	6.69e-05	0.00118	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—ICAM1—malaria	6.59e-05	0.00117	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—IL1B—malaria	6.52e-05	0.00115	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	6.5e-05	0.00115	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL10—malaria	6.47e-05	0.00115	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CD40LG—malaria	6.47e-05	0.00115	CbGpPWpGaD
Naloxone—CREB1—NCAM signaling for neurite out-growth—IL6—malaria	6.47e-05	0.00115	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—HPGDS—malaria	6.45e-05	0.00114	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL18—malaria	6.37e-05	0.00113	CbGpPWpGaD
Naloxone—CREB1—Immune System—FCGR2B—malaria	6.37e-05	0.00113	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD40LG—malaria	6.35e-05	0.00112	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—IL6—malaria	6.32e-05	0.00112	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL4—malaria	6.3e-05	0.00111	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD8A—malaria	6.28e-05	0.00111	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CD4—malaria	6.19e-05	0.0011	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IFNG—malaria	6.16e-05	0.00109	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FCGR2A—malaria	6.16e-05	0.00109	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-B—malaria	6.16e-05	0.00109	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—ACKR1—malaria	6.09e-05	0.00108	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—ACKR1—malaria	6.07e-05	0.00108	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-B—malaria	6.04e-05	0.00107	CbGpPWpGaD
Naloxone—CREB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	5.98e-05	0.00106	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD36—malaria	5.92e-05	0.00105	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—FAS—malaria	5.8e-05	0.00103	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	5.73e-05	0.00101	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—IL1B—malaria	5.71e-05	0.00101	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—CRP—malaria	5.7e-05	0.00101	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL1B—malaria	5.68e-05	0.00101	CbGpPWpGaD
Naloxone—CREB1—Immune System—TIRAP—malaria	5.68e-05	0.00101	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—IL6—malaria	5.57e-05	0.000986	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IL1B—malaria	5.5e-05	0.000974	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—malaria	5.41e-05	0.000958	CbGpPWpGaD
Naloxone—CREB1—MyD88 cascade initiated on plasma membrane—IL6—malaria	5.41e-05	0.000958	CbGpPWpGaD
Naloxone—CREB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	5.36e-05	0.000949	CbGpPWpGaD
Naloxone—TLR4—Immune System—CRP—malaria	5.34e-05	0.000945	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—ACKR1—malaria	5.33e-05	0.000943	CbGpPWpGaD
Naloxone—CREB1—Immune System—CR1—malaria	5.28e-05	0.000935	CbGpPWpGaD
Naloxone—CREB1—MyD88 dependent cascade initiated on endosome—IL6—malaria	5.26e-05	0.000932	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—ICAM1—malaria	5.24e-05	0.000927	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	5.17e-05	0.000915	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—IL6—malaria	5.17e-05	0.000915	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—DHODH—malaria	5.13e-05	0.000908	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	5.08e-05	0.000899	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.04e-05	0.000893	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IFNG—malaria	5.01e-05	0.000888	CbGpPWpGaD
Naloxone—CREB1—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	4.99e-05	0.000884	CbGpPWpGaD
Naloxone—TLR4—Immune System—ICAM1—malaria	4.91e-05	0.000869	CbGpPWpGaD
Naloxone—CREB1—Disease—PKLR—malaria	4.87e-05	0.000863	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—KDR—malaria	4.87e-05	0.000862	CbGpPWpGaD
Naloxone—CREB1—MyD88-independent cascade—IL6—malaria	4.79e-05	0.000848	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—TNF—malaria	4.77e-05	0.000845	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—IL6—malaria	4.74e-05	0.00084	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.63e-05	0.00082	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	4.55e-05	0.000805	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	4.52e-05	0.000801	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—ACKR1—malaria	4.5e-05	0.000797	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	4.5e-05	0.000796	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR9—malaria	4.49e-05	0.000795	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL1B—malaria	4.47e-05	0.000792	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HBB—malaria	4.47e-05	0.000791	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL2—malaria	4.46e-05	0.000789	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC4A1—malaria	4.36e-05	0.000772	CbGpPWpGaD
Naloxone—CREB1—Disease—G6PD—malaria	4.34e-05	0.000769	CbGpPWpGaD
Naloxone—CREB1—Activated TLR4 signalling—IL6—malaria	4.31e-05	0.000763	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL6—malaria	4.14e-05	0.000733	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TNF—malaria	4.12e-05	0.00073	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—DECR1—malaria	4.1e-05	0.000726	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	4.05e-05	0.000717	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CD36—malaria	4.02e-05	0.000712	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—TNF—malaria	3.99e-05	0.000706	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	3.98e-05	0.000706	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IFNG—malaria	3.98e-05	0.000706	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—IL6—malaria	3.85e-05	0.000682	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—IL6—malaria	3.82e-05	0.000676	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IFNG—malaria	3.81e-05	0.000674	CbGpPWpGaD
Naloxone—TLR4—Immune System—IFNG—malaria	3.73e-05	0.000661	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—HBB—malaria	3.71e-05	0.000656	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD40LG—malaria	3.65e-05	0.000647	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HLA-B—malaria	3.62e-05	0.000641	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD8A—malaria	3.61e-05	0.00064	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—IL6—malaria	3.61e-05	0.000639	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—IL6—malaria	3.61e-05	0.000639	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD4—malaria	3.61e-05	0.000639	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ACKR1—malaria	3.6e-05	0.000637	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ACKR1—malaria	3.59e-05	0.000635	CbGpPWpGaD
Naloxone—CREB1—Immune System—FCGR2A—malaria	3.59e-05	0.000635	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL1B—malaria	3.55e-05	0.000629	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD36—malaria	3.55e-05	0.000628	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.51e-05	0.000621	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-B—malaria	3.48e-05	0.000616	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—KDR—malaria	3.47e-05	0.000615	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—HPGDS—malaria	3.46e-05	0.000613	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—IL6—malaria	3.45e-05	0.000611	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD36—malaria	3.41e-05	0.000604	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—IL6—malaria	3.4e-05	0.000602	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL1B—malaria	3.39e-05	0.000601	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL2—malaria	3.38e-05	0.000599	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—IL6—malaria	3.35e-05	0.000593	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—IL6—malaria	3.34e-05	0.000592	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL1B—malaria	3.33e-05	0.00059	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL6—malaria	3.33e-05	0.000589	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL2—malaria	3.32e-05	0.000588	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PKLR—malaria	3.3e-05	0.000585	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TNF—malaria	3.25e-05	0.000575	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—IL6—malaria	3.24e-05	0.000575	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—IL6—malaria	3.23e-05	0.000572	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IL6—malaria	3.22e-05	0.00057	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—IL6—malaria	3.21e-05	0.000569	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CRP—malaria	3.2e-05	0.000567	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—IL6—malaria	3.2e-05	0.000566	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ACKR1—malaria	3.15e-05	0.000557	CbGpPWpGaD
Naloxone—CREB1—Disease—DHFR—malaria	3.07e-05	0.000544	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—TLR4—malaria	3.07e-05	0.000543	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—CD36—malaria	3.02e-05	0.000536	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—IL6—malaria	3.01e-05	0.000533	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—IL6—malaria	3.01e-05	0.000533	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—IL6—malaria	3.01e-05	0.000533	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—IL6—malaria	2.98e-05	0.000528	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—IL6—malaria	2.95e-05	0.000523	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—G6PD—malaria	2.94e-05	0.000521	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—IL6—malaria	2.94e-05	0.000521	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—malaria	2.91e-05	0.000514	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TLR9—malaria	2.9e-05	0.000514	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TLR9—malaria	2.89e-05	0.000512	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.86e-05	0.000507	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ICAM1—malaria	2.82e-05	0.0005	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—IL6—malaria	2.72e-05	0.000481	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.66e-05	0.000472	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ACKR1—malaria	2.66e-05	0.000471	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL6—malaria	2.62e-05	0.000464	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—malaria	2.58e-05	0.000457	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	2.57e-05	0.000456	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TLR9—malaria	2.54e-05	0.000449	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—DHODH—malaria	2.52e-05	0.000446	CbGpPWpGaD
Naloxone—ALB—Metabolism—DHODH—malaria	2.5e-05	0.000444	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.48e-05	0.000439	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.46e-05	0.000436	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—malaria	2.46e-05	0.000436	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ACKR1—malaria	2.36e-05	0.000418	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.3e-05	0.000407	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.27e-05	0.000403	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.26e-05	0.000401	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—HPGDS—malaria	2.25e-05	0.000398	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—IL6—malaria	2.23e-05	0.000394	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL18—malaria	2.22e-05	0.000394	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD40LG—malaria	2.22e-05	0.000392	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—DHODH—malaria	2.19e-05	0.000389	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD8A—malaria	2.19e-05	0.000388	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—malaria	2.16e-05	0.000383	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TLR9—malaria	2.14e-05	0.00038	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC4A1—malaria	2.14e-05	0.000379	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC4A1—malaria	2.13e-05	0.000377	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-B—malaria	2.11e-05	0.000373	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—DHFR—malaria	2.08e-05	0.000369	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL6—malaria	2.08e-05	0.000369	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—malaria	2.08e-05	0.000368	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD36—malaria	2.07e-05	0.000366	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SCARB1—malaria	2.06e-05	0.000365	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—malaria	2.05e-05	0.000363	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—DECR1—malaria	2.01e-05	0.000357	CbGpPWpGaD
Naloxone—ALB—Metabolism—DECR1—malaria	2e-05	0.000355	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—malaria	1.95e-05	0.000345	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TLR9—malaria	1.9e-05	0.000337	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC4A1—malaria	1.87e-05	0.00033	CbGpPWpGaD
Naloxone—CREB1—Immune System—CRP—malaria	1.86e-05	0.00033	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—malaria	1.85e-05	0.000328	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HBB—malaria	1.82e-05	0.000323	CbGpPWpGaD
Naloxone—ALB—Metabolism—HBB—malaria	1.81e-05	0.000321	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR4—malaria	1.79e-05	0.000316	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—DECR1—malaria	1.75e-05	0.000311	CbGpPWpGaD
Naloxone—CREB1—Immune System—ICAM1—malaria	1.71e-05	0.000303	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL2—malaria	1.69e-05	0.0003	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—malaria	1.64e-05	0.00029	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PKLR—malaria	1.62e-05	0.000287	CbGpPWpGaD
Naloxone—ALB—Metabolism—PKLR—malaria	1.61e-05	0.000286	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HBB—malaria	1.59e-05	0.000281	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS2—malaria	1.57e-05	0.000278	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CD36—malaria	1.56e-05	0.000276	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—G6PD—malaria	1.45e-05	0.000256	CbGpPWpGaD
Naloxone—ALB—Metabolism—G6PD—malaria	1.44e-05	0.000255	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.43e-05	0.000253	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.42e-05	0.000251	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PKLR—malaria	1.41e-05	0.00025	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL2—malaria	1.39e-05	0.000246	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DHODH—malaria	1.35e-05	0.000239	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—malaria	1.32e-05	0.000234	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNG—malaria	1.3e-05	0.000231	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CD36—malaria	1.29e-05	0.000229	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS2—malaria	1.28e-05	0.000227	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL2—malaria	1.27e-05	0.000224	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL2—malaria	1.26e-05	0.000224	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—G6PD—malaria	1.26e-05	0.000223	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—malaria	1.26e-05	0.000223	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL2—malaria	1.22e-05	0.000216	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.22e-05	0.000215	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—malaria	1.17e-05	0.000207	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—malaria	1.16e-05	0.000206	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—malaria	1.16e-05	0.000206	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2—malaria	1.16e-05	0.000205	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KDR—malaria	1.16e-05	0.000205	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KDR—malaria	1.15e-05	0.000204	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC4A1—malaria	1.15e-05	0.000204	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2—malaria	1.11e-05	0.000196	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HPGDS—malaria	1.1e-05	0.000195	CbGpPWpGaD
Naloxone—ALB—Metabolism—HPGDS—malaria	1.1e-05	0.000194	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DECR1—malaria	1.08e-05	0.000191	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2—malaria	1.03e-05	0.000183	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—DHFR—malaria	1.02e-05	0.000181	CbGpPWpGaD
Naloxone—ALB—Metabolism—DHFR—malaria	1.02e-05	0.00018	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SCARB1—malaria	1.01e-05	0.000179	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KDR—malaria	1.01e-05	0.000179	CbGpPWpGaD
Naloxone—ALB—Metabolism—SCARB1—malaria	1.01e-05	0.000178	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HBB—malaria	9.78e-06	0.000173	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HPGDS—malaria	9.61e-06	0.00017	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2—malaria	9.36e-06	0.000166	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—DHFR—malaria	8.92e-06	0.000158	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SCARB1—malaria	8.83e-06	0.000156	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2—malaria	8.74e-06	0.000155	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PKLR—malaria	8.71e-06	0.000154	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KDR—malaria	8.53e-06	0.000151	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—G6PD—malaria	7.77e-06	0.000138	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KDR—malaria	7.57e-06	0.000134	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2—malaria	7.49e-06	0.000133	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2—malaria	7.46e-06	0.000132	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—malaria	7.45e-06	0.000132	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—malaria	7.43e-06	0.000132	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—malaria	6.81e-06	0.000121	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2—malaria	6.54e-06	0.000116	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—malaria	6.51e-06	0.000115	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CD36—malaria	6.36e-06	0.000113	CbGpPWpGaD
Naloxone—ALB—Metabolism—CD36—malaria	6.32e-06	0.000112	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—malaria	6.28e-06	0.000111	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HPGDS—malaria	5.92e-06	0.000105	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CD36—malaria	5.54e-06	9.81e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2—malaria	5.53e-06	9.8e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—malaria	5.5e-06	9.75e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DHFR—malaria	5.49e-06	9.73e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SCARB1—malaria	5.44e-06	9.63e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2—malaria	4.9e-06	8.69e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—malaria	4.4e-06	7.79e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—malaria	4.39e-06	7.77e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—malaria	3.85e-06	6.81e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CD36—malaria	3.41e-06	6.04e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—malaria	3.25e-06	5.76e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—malaria	2.88e-06	5.11e-05	CbGpPWpGaD
